PRESS RELEASE published on 02/25/2025 at 22:01, 1 year 2 months ago DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress DBV Technologies to participate in AAAAI/WAO Joint Congress to present long-term efficacy results of epicutaneous immunotherapy with VIASKIN peanut patch in peanut-allergic children aged 4-11 years, showcasing treatment benefits and high compliance rates DBV Technologies Epicutaneous Immunotherapy Viaskin Peanut Patch AAAAI/WAO Joint Congress PEPITES Study
BRIEF published on 01/13/2025 at 22:10, 1 year 3 months ago Bilan de Liquidité Semestriel de DBV Technologies Contrat De Liquidité ODDO BHF Transactions Boursières DBV Technologies VIASKIN®
BRIEF published on 01/13/2025 at 22:10, 1 year 3 months ago DBV Technologies Half-Yearly Liquidity Statement Liquidity Contract ODDO BHF Stock Market Transactions DBV Technologies VIASKIN®
PRESS RELEASE published on 01/13/2025 at 22:05, 1 year 3 months ago Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF DBV Technologies publie le bilan semestriel de son contrat de liquidité avec ODDO BHF. Détails des transactions et volumes échangés. Focus sur le patch VIASKIN® pour les allergies alimentaires Contrat De Liquidité ODDO BHF DBV Technologies Allergies Alimentaires Patch VIASKIN®
PRESS RELEASE published on 01/13/2025 at 22:05, 1 year 3 months ago Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies issues Half-Year Report on liquidity contract with ODDO BHF, revealing assets in the account and transaction details Liquidity Contract Half-year Report Biopharmaceutical Company ODDO BHF DBV Technologies
BRIEF published on 12/02/2024 at 22:35, 1 year 5 months ago DBV Technologies : Droits de vote et actions au 30 novembre 2024 Droits De Vote Capital Social Actions DBV Technologies NYSE Euronext Paris
BRIEF published on 12/02/2024 at 22:35, 1 year 5 months ago DBV Technologies: Voting rights and shares as of November 30, 2024 Share Capital Voting Rights Actions DBV Technologies NYSE Euronext Paris
PRESS RELEASE published on 12/02/2024 at 22:30, 1 year 5 months ago Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 novembre 2024 Nombre total des droits de vote et d'actions composant le capital social au 30 novembre 2024 selon l'AMF Droits De Vote Capital Social Actions AMF NYSE Euronext Paris
PRESS RELEASE published on 12/02/2024 at 22:30, 1 year 5 months ago Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024 Company provides update on total voting rights and shares as of November 30, 2024 in compliance with AMF regulations Shares Total Voting Rights AMF Regulations NYSE Euronext Paris November 30 2024
BRIEF published on 11/20/2024 at 15:33, 1 year 5 months ago Franchissement de Seuils par Braidwell LP chez DBV Technologies Investissement Actions Franchissement De Seuils DBV Technologies Braidwell LP
Published on 05/09/2026 at 00:00, 1 hour 21 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:00, 2 hours 21 minutes ago Digi Power X Announces Upsizing of At-the-Market Offering Program
Published on 05/08/2026 at 22:30, 2 hours 51 minutes ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026
Published on 05/08/2026 at 22:30, 2 hours 51 minutes ago Sekur Private Data Advances Defense-Grade Secure Communications Platform
Published on 05/08/2026 at 20:38, 4 hours 43 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 6 hours 8 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 6 hours 18 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 6 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 6 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 6 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 6 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 6 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
